Flyer

Health Science Journal

  • ISSN: 1108-7366
  • Journal h-index: 51
  • Journal CiteScore: 10.69
  • Journal Impact Factor: 9.13
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
Share This Page

Abstract

N-linked Glycosylation and its Potential Application in Drug Development

Shilei Wang, Quanyong He, Jinlei Ye, Zhichao Kang, Qiping Zheng, Shuo Liu, Jun He and Lichun Sun

Protein glycosylation is a site-specific enzymatic process to attach oligosaccharides or carbohydrates to proteins. N-linked glycosylation (N-glycosylation) is the major type of glycosylation for the post-translational and co-translational modification of proteins in eukaryotic cells. N-linked glycosylation is to link saccharide molecules to proteins via covalently coupling oligosaccharides or glycans to the amino acid residue asparagine (Asn, N) of proteins, mostly with the requirement of a Asn–X–Ser/Thr (N-X-S/T) consensus sequence. N-linked protein glycosylation is of significance and plays critical roles in biological and pathological processes, and also applied for modern drug development. Particularly, the strategy to engineer N-linked glycosylation site(s) can stabilize the recombinant fusion proteins. This technology has been widely applied for drug discovery, especially for the peptide drugs such as rabies viral glycoprotein (RVG), cardiac-targeting peptide (CTP), bovine adrenal medulla (BAM).